Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes
Completed clinical trial evaluating the effects of a very-low-calorie diet (VLCD) and bariatric surgery in patients with type 2 diabetes mel…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity [NA]
A completed clinical trial evaluating the effect of a multi-ingredient intervention on visceral adiposity and non-alcoholic fatty liver dise…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease [Phase 2]
A Phase 2 clinical trial evaluating the Chazhu Xiaozhi Decoction for non-alcoholic fatty liver disease has completed, providing updated resu…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Dairy Protien Rich Diet for NAFLD Patients [NA]
A clinical trial evaluating a dairy protein–rich diet for patients with non-alcoholic fatty liver disease and metabolic syndrome has complet…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795 [Phase 1]
This Phase 1, dose-escalation study of subcutaneously administered JNJ-75220795 has completed in patients with non-alcoholic fatty liver dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: 12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat [NA]
A completed clinical trial update suggests that 12 months of once-a-week HIIT improves body adiposity and liver fat in people with non-alcoh…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Antidiabetic Drugs for Steatotic Liver Disease [Phase 4]
Phase 4 clinical trial update evaluating antidiabetic drugs for steatotic liver disease (MASLD) and type 2 diabetes; the study has completed…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease [Phase 2]
A Phase 2 clinical trial evaluating metabolic cofactor supplementation in obese patients with non-alcoholic fatty liver disease has complete…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
A Phase 2 clinical trial evaluating Proliverenol supplementation for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
A clinical trial update indicates a study is examining the potential increased risk of non-alcoholic fatty liver disease in individuals with…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD [Phase 4]
Phase 4 study evaluating berberine for reducing abdominal visceral adipose tissue in individuals with obesity and NAFLD has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD [Phase 1]
Phase 1 study evaluating multiple-dose Efocipegtrutide (HM15211) in obese subjects with non-alcoholic fatty liver disease has completed, wit…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Vigabatrin and Insulin Sensitivity [Phase 2]
Phase 2 clinical trial evaluating vigabatrin for insulin sensitivity in non-alcoholic fatty liver disease and obesity has completed and resu…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Effect of Obesity on Proton Pump Inhibitors [Phase 4]
Phase 4 trial completed evaluating whether obesity affects the use or effectiveness of proton pump inhibitors in obesity with NAFLD and GERD…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes [NA]
A completed clinical trial update from Duke University examining improved detection and evidence-based care of non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD) [NA]
Completed trial evaluating the effect of an exercise program on insulin resistance in non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Manual Therapy in Metabolic Liver Disease [NA]
A completed University of Seville clinical trial evaluated manual therapy for non-alcoholic fatty liver disease (NAFLD).
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease
This update reports the completion of a clinical trial evaluating lysosomal acid lipase activity in individuals with non-alcoholic fatty liv…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome [NA]
This clinical trial update notes that a study on smartphone app–assisted eating patterns and time-restricted feeding in metabolic syndrome h…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: A Feasibility Trial of OCM Supplements for the Treatment of NAFLD [EARLY_Phase 1]
A completed early-phase feasibility trial evaluating OCM dietary supplements for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease [NA]
Clinical trial evaluating tocotrienol for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Healthy Liver - Healthy Brain [NA]
A completed clinical trial conducted by the University of Texas at Austin studied the relationship between metabolic syndrome, non-alcoholic…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients [NA]
A completed clinical trial comparing strategies for screening, referral, and management of diabetic patients with non-alcoholic fatty liver …
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Soluble Fibre Supplementation in NAFLD [Phase 2]
A Phase 2 clinical trial is evaluating soluble fibre supplementation for non-alcoholic fatty liver disease and related conditions and is cur…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD [NA]
A completed clinical trial evaluated the effects of time-restricted hypocaloric dieting in individuals with non-alcoholic fatty liver diseas…